INTCINTC
US • TECHNOLOGY
$92.32
P/E
—
PEG
0.50
FCF Yield
0.2%
Rev Growth YoY
+7.2% YoY
Gross Margin
37.2%
Health Score
6/10
D/E Ratio
0.41
Confidence
MEDIUM
Business Snapshot
Intel Corporation is a dominant player in the semiconductor industry, primarily known for designing and manufacturing central processing units (CPUs) for personal computers and data centers. The company operates in the highly cyclical and capital-intensive semiconductor market, facing intense competition from rivals like AMD and NVIDIA. As a large-cap company with a market capitalisation of $465.66B and trailing twelve-month (TTM) revenue of $53.76B, Intel possesses substantial financial scale. A defining characteristic is its vertical integration, as it both designs and manufactures its own chips, a capital-intensive model that presents both a potential competitive moat and significant financial risk. The company is currently navigating a major strategic turnaround to regain process technology leadership.
Financial Health
Intel’s financial health presents a mixed picture with a solid balance sheet but weak profitability. The company’s gross margin of 37.2% and negative net margin of -5.9% are concerning, indicating the company is currently operating at a net loss...
Risk Assessment
- EARNINGS QUALITY — The company has a negative net margin of -5.9% and TTM net income of -$3.03B, indicating core operations are unprofitable.
- VALUATION — With a P/E ratio that is N/A due to negative earnings, and a Price/Sales ratio of 8.66x, the stock is priced for a significant recovery that has not yet materialised.
- 52-WEEK POSITION — The current price of $92.32 is 35% below the 52-week high of $142.35, reflecting significant downward momentum from the peak.
- VALUATION DIVERGENCE — The Python DCF estimate of $1.88 implies the stock is significantly overvalued, though this model carries high uncertainty, creating sharp divergence with an analyst price target representing 25% upside.
- TECHNICALS — The price is currently below the 50-day moving average of $115.83, indicating short-term bearish momentum....
Intel’s financial health presents a mixed picture with a solid balance sheet but weak profitability. The company’s gross margin of 37.2% and negative net margin of -5.9% are concerning, indicating the company is currently operating at a net loss. The balance sheet is conservatively structured with a low Debt/Equity ratio of 0.41x and a healthy current ratio of 2.02x, providing significant financial flexibility. The company is generating positive free cash flow (FCF) of $886.28M, though the FCF yield is a very low 0.2%, suggesting the market capitalisation is high relative to this cash generation. Overall, while the strong balance sheet supports reinvestment into the turnaround, the negative net margin and low cash flow yield limit the company's dividend capacity and highlight near-term profitability challenges.
- EARNINGS QUALITY — The company has a negative net margin of -5.9% and TTM net income of -$3.03B, indicating core operations are unprofitable. - VALUATION — With a P/E ratio that is N/A due to negative earnings, and a Price/Sales ratio of 8.66x, the stock is priced for a significant recovery that has not yet materialised. - 52-WEEK POSITION — The current price of $92.32 is 35% below the 52-week high of $142.35, reflecting significant downward momentum from the peak. - VALUATION DIVERGENCE — The Python DCF estimate of $1.88 implies the stock is significantly overvalued, though this model carries high uncertainty, creating sharp divergence with an analyst price target representing 25% upside. - TECHNICALS — The price is currently below the 50-day moving average of $115.83, indicating short-term bearish momentum.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives